Biocon Biologics (BBL), a subsidiary of Biocon, today announced the successful pricing of Biocon Biologics’ debut USD 800 million (Rs 6676.3 crore) senior secured Notes due 2029 at a coupon of 6.67%.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
